InvestorsHub Logo
icon url

docprep

07/20/18 5:20 AM

#46514 RE: Stock_Goodies #46499

True.

But you know as well as I do that big pharma is in the treatment and keep you sick business, not the cures business.

Its a numbers game. If by gaining that 30%, it hits their 70% bottom line, it wouldn't be worth it for them.

What we would need for buyout is big company that doesn't have anything in the ED space that wants to rival pfizer. So pfizer, merck wouldn't be good. Especially with viagra patent expiring.

Johnson and johnson maybe?